SMT201500032B - Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete - Google Patents

Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete

Info

Publication number
SMT201500032B
SMT201500032B SM201500032T SM201500032T SMT201500032B SM T201500032 B SMT201500032 B SM T201500032B SM 201500032 T SM201500032 T SM 201500032T SM 201500032 T SM201500032 T SM 201500032T SM T201500032 B SMT201500032 B SM T201500032B
Authority
SM
San Marino
Prior art keywords
insulin
diabetes
treatment
combination
triazine derivatives
Prior art date
Application number
SM201500032T
Other languages
English (en)
Italian (it)
Inventor
Daniel Cravo
Didier Mesangeau
Annick Audet
Original Assignee
Poxel Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel Sas filed Critical Poxel Sas
Publication of SMT201500032B publication Critical patent/SMT201500032B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SM201500032T 2008-12-12 2015-02-11 Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete SMT201500032B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08021617 2008-12-12
PCT/EP2009/008099 WO2010066326A1 (en) 2008-12-12 2009-11-13 Combination of insulin with triazine derivatives and its use for treating diabetes

Publications (1)

Publication Number Publication Date
SMT201500032B true SMT201500032B (it) 2015-05-05

Family

ID=41566311

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500032T SMT201500032B (it) 2008-12-12 2015-02-11 Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete

Country Status (23)

Country Link
US (2) US8592370B2 (xx)
EP (1) EP2355829B1 (xx)
JP (1) JP5667985B2 (xx)
KR (1) KR101623819B1 (xx)
CN (1) CN102245185A (xx)
AR (1) AR074555A1 (xx)
AU (1) AU2009326604B2 (xx)
BR (1) BRPI0923373B8 (xx)
CA (1) CA2746479C (xx)
CY (1) CY1115973T1 (xx)
DK (1) DK2355829T3 (xx)
EA (1) EA021395B1 (xx)
ES (1) ES2530223T3 (xx)
HR (1) HRP20150064T1 (xx)
IL (1) IL213421A (xx)
MX (1) MX2011006073A (xx)
PL (1) PL2355829T3 (xx)
PT (1) PT2355829E (xx)
SG (1) SG171986A1 (xx)
SI (1) SI2355829T1 (xx)
SM (1) SMT201500032B (xx)
WO (1) WO2010066326A1 (xx)
ZA (1) ZA201105094B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154496A1 (en) * 2010-06-09 2011-12-15 Poxel Treatment of type 1 diabetes
TWI436768B (zh) * 2010-06-09 2014-05-11 Poxel 第２型糖尿病之治療
MX359171B (es) * 2011-12-12 2018-09-18 Melior Pharmaceuticals I Inc Tratamiento para diabetes tipo i y tipo ii.
WO2019069230A1 (en) 2017-10-02 2019-04-11 Poxel METHODS OF TREATING CARDIAC INSUFFICIENCY WITH PRESERVED EJECTION FRACTION
AU2019282727A1 (en) 2018-06-06 2020-11-26 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
MX2020013567A (es) 2018-06-14 2021-05-27 Poxel Tableta recubierta con pelicula que comprende un derivado de triazina para su uso en el tratamiento de la diabetes.
WO2021117861A1 (ja) * 2019-12-13 2021-06-17 大日本住友製薬株式会社 製造性及び溶出性に優れた小型錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172814A (en) * 1962-04-06 1965-03-09 Jr Edgar A Ferguson Oral blood sugar lowering compositions
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
EP1355651A2 (en) * 2001-02-02 2003-10-29 Pfizer Limited Treatment of diabetes mellitus using vardenafil
DE10301788B4 (de) 2003-01-20 2005-08-25 Aventis Pharma Deutschland Gmbh Pharmazeutische Verwendung von Pyrimido[5,4-e][1,2,4]triazin-5,7-dionen
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
FR2896157B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.

Also Published As

Publication number Publication date
EP2355829A1 (en) 2011-08-17
SG171986A1 (en) 2011-07-28
BRPI0923373B1 (pt) 2020-02-11
BRPI0923373A2 (pt) 2015-07-21
AR074555A1 (es) 2011-01-26
EA201100916A1 (ru) 2012-01-30
US20110306543A1 (en) 2011-12-15
US8592370B2 (en) 2013-11-26
CY1115973T1 (el) 2017-01-25
US8980828B2 (en) 2015-03-17
CA2746479A1 (en) 2010-06-17
US20130310312A1 (en) 2013-11-21
JP5667985B2 (ja) 2015-02-12
KR101623819B1 (ko) 2016-05-24
SI2355829T1 (sl) 2015-03-31
PL2355829T3 (pl) 2015-04-30
KR20110106354A (ko) 2011-09-28
EP2355829B1 (en) 2014-12-31
MX2011006073A (es) 2011-06-24
DK2355829T3 (en) 2015-02-16
CA2746479C (en) 2016-11-08
IL213421A0 (en) 2011-07-31
HRP20150064T1 (hr) 2015-02-27
JP2012511521A (ja) 2012-05-24
IL213421A (en) 2017-02-28
WO2010066326A1 (en) 2010-06-17
AU2009326604B2 (en) 2014-07-31
EA021395B1 (ru) 2015-06-30
ES2530223T3 (es) 2015-02-27
AU2009326604A1 (en) 2011-07-28
CN102245185A (zh) 2011-11-16
BRPI0923373B8 (pt) 2021-05-25
PT2355829E (pt) 2015-02-20
ZA201105094B (en) 2012-03-28

Similar Documents

Publication Publication Date Title
SMT201500032B (it) Combinazione di insulina con derivati di triazina e suo uso per il trattamento del diabete
CL2007003033A1 (es) Compuestos derivados de benzoilamino heterociclos; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso del compuesto en el tratamiento de la diabetes tipo ii.
SMT201600258B (it) Composto indolico e suo uso farmaceutico
DK2242409T3 (da) Engangspumpe med tilbagesugningsmekanisme
CL2011003350A1 (es) Compuestos derivados de heterociclo nitrogenados, moduladores pkm2; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer.
SMT201600225B (it) DERIVATI DI 1,2,4-TIAZOLlDIN-3-0NE E LORO USO NEL TRATTAMENTO DEL CANCRO
DK3517534T3 (da) Forbindelser, der er anvendelige til behandling af cancer
BRPI0917535A2 (pt) uso de insulina de ação ultra rápida
CL2007002296A1 (es) Compuestos derivados de imidazolina-2,4-dionas sustituidas con arilaminoalquilo; composicion farmaceutica; y uso del compuesto en el tratamiento del sindrome metabolico, diabetes, obesidad, dependencia de la nicotina, dependencia del alcohol, trastor
CL2014000801A1 (es) Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos.
CL2013002053A1 (es) Compuestos derivados de heterociclicos, antagonistas del receptor de glucagon; composicion farmaceutica que lo comprende y su uso en el tratamiento de diabetes y enfermedades metabolicas. pct
CL2008001271A1 (es) Compuestos derivados de heterociclos de nitrogeno y oxigeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, hiperglicemia, intolerancia a la glucosa, aterosclerosis, dislipidemia, obesid
UY31596A1 (es) Nuevos derivados de insulina con perfil tiempo/accion extremadamente retardado
BRPI1013642A2 (pt) derivado de triazina e composição farmacêutica compreendendo o mesmo
CL2011001299A1 (es) Compuestos derivados de benzotiazoles; composicion farmaceutica; y su uso como inhibidores de raf para el tratamiento o profilaxis del cancer.
BRPI0909639A2 (pt) Barra de carboidrato e uso da mesma
DK2337597T3 (da) Medicinsk injektor med koblede legemsenheder
CL2012001321A1 (es) Compuestos derivados de espiro inden (o indan) - 1,4-piperidin o espiro indolin - 3,4-piperidin, activadores gpr40; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes.
BRPI0908519A2 (pt) dispositivo eletrocrômico com transparência controlada, notadamente de tipo eletrocomandável, conjunto de vidraças eletrocrômicas, e, utilização do conjunto
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
SMT201300030B (it) Uso del pasireotide per il trattamento di ipoglicemia iperinsulinemica endogena
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
CL2008003546A1 (es) Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii.
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.